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Morten Trillingsgaard Venø 3, Jørgen Kjems 3, D. Ross Laybutt 2, Romano Regazzi 1,*ABSTRACT
Objective: There is strong evidence for an involvement of different classes of non-coding RNAs, including microRNAs and long non-coding RNAs,
in the regulation of b-cell activities and in diabetes development. Circular RNAs were recently discovered to constitute a substantial fraction of the
mammalian transcriptome but the contribution of these non-coding RNAs in physiological and disease processes remains largely unknown. The
goal of this study was to identify the circular RNAs expressed in pancreatic islets and to elucidate their possible role in the control of b-cells
functions.
Methods: We used a microarray approach to identify circular RNAs expressed in human islets and searched their orthologues in RNA sequencing
data from mouse islets. We then measured the level of four selected circular RNAs in the islets of different Type 1 and Type 2 diabetes models and
analyzed the role of these circular transcripts in the regulation of insulin secretion, b-cell proliferation, and apoptosis.
Results: We identiﬁed thousands of circular RNAs expressed in human pancreatic islets, 497 of which were conserved in mouse islets. The level
of two of these circular transcripts, circHIPK3 and ciRS-7/CDR1as, was found to be reduced in the islets of diabetic db/db mice. Mimicking this
decrease in the islets of wild type animals resulted in impaired insulin secretion, reduced b-cell proliferation, and survival. ciRS-7/CDR1as has
been previously proposed to function by blocking miR-7. Transcriptomic analysis revealed that circHIPK3 acts by sequestering a group of
microRNAs, including miR-124-3p and miR-338-3p, and by regulating the expression of key b-cell genes, such as Slc2a2, Akt1, and Mtpn.
Conclusions: Our ﬁndings point to circular RNAs as novel regulators of b-cell activities and suggest an involvement of this novel class of non-
coding RNAs in b-cell dysfunction under diabetic conditions.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Pancreatic b-cells are the sole source of insulin, a peptide hormone
essential to regulation of blood glucose homeostasis. Defective insulin
secretion can lead to chronic hyperglycemia and the development of
diabetes mellitus [1]. Type 1 Diabetes is characterized by a chronic
autoimmune attack of the b-cells resulting in complete (or near
complete) insulin deﬁciency and sustained hyperglycemia [2]. In
contrast, Type 2 Diabetes, the most common form of the disease, is
caused by the failure of b-cells to cope with systemic insulin resis-
tance elicited by environmental factors [1,3].
b-cell dysfunction and failure under diabetic conditions is associated
with alterations in the expression of protein-coding and non-coding
transcripts. There is already strong evidence indicating that different
types of non-coding RNAs, including microRNAs (miRNAs) and long
non-coding RNAs, are key players in the regulation of b-cell functions
and in the development of diabetes [4,5]. However, the role of the
newly discovered class of circular RNAs (circRNAs) remains to be
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ago [6], but they were considered the result of rare splicing errors.
Contrary to this assumption, recent work revealed the presence of
thousands of abundant, endogenous circRNAs in mammalian cells [7].
These transcripts are characterized by a covalently closed loop, which
is formed by direct backsplicing in a non-canonical order [6]. CircRNAs
are generally not poly-adenylated, lack cap structures, and are
expressed in cell-type speciﬁc manners [8]. Recent evidence suggests
that circRNAs can be translated in vivo in a cap-independent manner
[9]; however, most circRNAs do not encode for proteins.
Despite their abundance, little is known about the functional role of
circRNAs. Some circRNAs, mostly intronic isoforms, control the
expression of their parent gene [8,10,11]. In addition, circRNAs can
also function via the association to RNA-binding proteins [12], and they
might play a role in the regulation of alternative splicing by competing
with the splicing of linear transcripts [13]. Some circRNAs have been
proposed to act as endogenous miRNA sponges [14]. There are just a
few circRNAs containing numerous miRNA seed sites, but new evi-
dence suggests that some circRNAs can act by the combinationalbetes and Metabolism Division, Garvan Institute of Medical Research, Darlinghurst,
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Original Articlesponging of several miRNAs [15,16]. In fact, it was demonstrated that
circFoxo3 regulates Foxo3 translation by sponging eight different
miRNAs [17] and controls proliferation by producing a ternary complex
with p21 and CDK2 [18]. Another example of a miRNA sponge is ciRS-
7 (also called CDR1as), which possesses more than 70 binding sites
for miR-7 [14], and has been shown to regulate insulin content and
secretion of mouse islets [19]. Until now, the latter study represents
the only evidence of circRNA control of b-cell activities.
The aim of the present study was to identify circRNAs expressed in
pancreatic islets and to elucidate their possible role in the control of b-
cells functions. For this purpose, we analyzed the expression of
thousands previously annotated circRNAs in human islets and
conﬁrmed the expression of four of them in human, mouse, and rat b-
cells. We found that circHIPK3 and ciRS-7 are highly abundant in
pancreatic islets and display reduced expression in diabetes animal
models. Silencing these circular transcripts resulted in impaired b-cell
function, pointing to a contribution of altered circHIPK3 and ciRS-7
expression to the development of diabetes mellitus.
2. MATERIAL & METHODS
2.1. Chemicals
Recombinant mouse IL-1b, BSA, poly-L-lysine, prolactin, Histopaque
1119 and 1077 were purchased from Sigma. Recombinant mouse
TNF-a was purchased from Enzo Life Sciences, recombinant mouse
IFN-g from R&D Systems, and Hoechst dye 33,342 from Invitrogen.
2.2. Animals
10e12 weeks old Wistar Han male rats were obtained from JANVIER
LABS, and NOD and NOD/SCID mice at 4 and 8 weeks of age from
Charles River Laboratories. 13e16 weeks old C57BL/KsJ db/db and
C57BL/6J ob/ob mice, as well as their respective heterozygous and
wildtype control mice were taken from the Garvan Institute breeding
colonies [20]. All procedures followed the guidelines issued by the
National Health and Medical Research Council of Australia, and of the
Swiss research council and veterinary ofﬁces.
2.3. Human islets
Human islets were provided by the Cell Isolation and Transplantation
Centre (University of Geneva) through JDRF award 31-2008-413 and
31-2008-416 (ECIT Islet for Basic Research Program). The use of
human islets was approved by the Geneva institutional Ethics
Committee.
2.4. Tissue expression
For expression analysis, tissues from Wistar Han male rats were blast-
frozen in liquid nitrogen and lysed in Qiazol (Qiagen). Afterwards, the
samples were homogenized with a tissue ruptor (Qiagen) and RNA
isolated using the miRNeasy kit (Qiagen).
2.5. Isolation, culture and dissociation of rat islets
Rat islets were isolated by collagenase (Roche) digestion [21] and
collected by a Histopaque density gradient. Islets were cultured in
RPMI 1640 Glutamax medium (Invitrogen) supplemented with 10%
fetal calf serum (Gibco), penicillin 50 U/ml, streptomycin 50 mg/ml
(Gibco), 1 mM Na Pyruvate (SigmaeAldrich), and 10 mM Hepes
(Sigma). Islets were dispersed using Trypsin-EDTA (Gibco).
2.6. Culture of MIN6B1 cells
The murine insulin-secreting cell line MIN6B1 [22] was cultured in
DMEM-Glutamax medium (Invitrogen), supplemented with 15% fetal70 MOLECULAR METABOLISM 9 (2018) 69e83  2018 The Authors. Published by Elsevier GmbH.calf serum (Gibco), 50 U/ml penicillin, 50 mg/ml streptomycin (Gibco),
and 70 mM b-mercaptoethanol (Sigma). The MIN6B1 cells tested
negative for mycoplasma contamination.
2.7. Microarray and RNA sequencing proﬁling
For mRNA proﬁling, RNA from MIN6B1 cells treated for 48 h with
circHIPK3 siRNA, and control siRNA was extracted with the miRNeasy
kit (Qiagen). Global mRNA expression proﬁling and data analysis were
carried out using Mouse Gene Expression Array v.2 (Arraystar). For
circRNA proﬁling, RNA from human islets was extracted with the
RNeasy kit (Qiagen) and treated with RNase R to deplete the samples
from the linear transcripts. CircRNA expression proﬁling and data
analysis were carried after out using Human CircRNA Array v1.0
(Arraystar). In addition, circular RNAs were annotated in published
mouse islet RNA sequencing data (ND samples) [23] as previously
described [24]. Conserved circRNA backsplicing was examined by
mapping human circRNAs from the human genome (hg19) to the
mouse genome (mm10) using USCS liftOver tool. Afterwards, the
mouse islet data set was screened for precise orthologous splicing to
obtain the list of conserved circRNAs (GSE105096).
2.8. Quantitative real-time PCR and sequencing
For mRNA or circRNA ampliﬁcation, total RNA isolated using miRNeasy
kit (Qiagen) was treated with RQ1 RNase-free DNase (Promega) and
reverse transcribed using Moloney murine leukaemia virus (M-MLV)
reverse transcriptase, RNAse H minus (Promega). Real-time PCR was
performed with SsoAdvanced Universal SYBR Green supermix
(Biorad) on the CFX Connect Real-Time PCR System (Biorad). The
relative expression was normalized to the level of a housekeeping
gene. For circRNA ampliﬁcation divergent primer sets were used.
Primer sequences are listed in the supplementary material
(Supplementary Table 1). For sequencing, PCR products were cleaned
using the Wizard SV Gel and PCR Clean-Up System (Promega), and
sequenced by Microsynth.
For miRNA ampliﬁcation, total RNA was reverse transcribed using
Universal cDNA synthesis kit II (Exiqon) and real-time PCR was per-
formed with ExiLENT SYBR Green master mix (Exiqon) according to
manufacturer’s instructions. Primer for miRNA ampliﬁcation were
purchased from Exiqon.
2.9. Veriﬁcation of circularity
MIN6B1 RNA was ﬁrst subjected to RQ1 RNase-free DNase (Promega)
treatment and then incubated for 15 min at 37 C with 3 U/mg RNase R
(Epicentre). Afterwards, RNase R was removed by re-isolating the RNA
with the miRNeasy kit (Qiagen).
2.10. Cell transfection
Transfection of dissociated rat islet cells or MIN6B1 cells was carried out
using Lipofectamine 2000 (Invitrogen) for plasmids or with Lipofectamine
RNAiMax (Invitrogen) for oligonucleotides. SiRNA sequences are listed in
the supplementary material (Supplementary Table 2). Hipk3 siRNA
against exon 16 was purchased from Life Technologies (#S800). All
assays were performed 48 h after transfection.
2.11. Insulin secretion
Dissociated rat islet cells or MIN6B1 cells were pre-incubated in
KREBS buffer containing 25 mM Hepes, 0.1% BSA, and 2 mM glucose
for 45 min at 37 C. Afterwards, the medium was replaced by either
KREBS buffer with 2 mM glucose (basal condition) or 20 mM glucose
(stimulatory condition). After 45 min, the supernatants were collected.
Cellular insulin content was recovered in EtOH acid (75% EtOH, 0.55%This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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HCl) from cells incubated under basal condition, and protein content in
Triton-X lysis buffer from cells under stimulatory condition. The amount
of insulin in the samples was assessed by ELISA (Mercodia) and
protein content by Bradford Assay (Thermo Fisher).
2.12. Immunocytochemistry
Dispersed rat islet cells or MIN6B1 cells were plated on poly-L-lysine-
coated coverslips. Proliferation was stimulated with 500 ng/ml pro-
lactin (SigmaeAldrich) for 48 h. The cells were ﬁxed with methanol
and permeabilized with PBS supplemented with 0.05% saponin
(Sigma). After 30 min in blocking buffer (PBS, 0.05% saponin, 1%
BSA), the cells were incubated for 1 h at room temperature with pri-
mary antibodies: 1:1300 rabbit anti-Ki67 (Abcam, #ab15580), 1:100
guinea pig anti-insulin (Dako, #A0564). Subsequently, the cells were
incubated for 1 h at room temperature with goat anti-rabbit Alexa Fluor
488 and goat anti-guinea pig Alexa Fluor 555 diluted at 1:500 (Invi-
trogen: #A11008 and #A21435, respectively). Afterwards, the cover-
slips were incubated for 10 min with Hoechst 33,342 (Invitrogen) and
mounted on glass slides using FluorSave Reagent (Millipore). The
cells were analyzed with a Zeiss Axio Imager Z1.
2.13. Cell death assessment
The fraction of apoptotic cells was determined by counting the cells
displaying pycnotic nuclei upon Hoechst staining under a ﬂuorescence
microscope (AxioCam MRc5, Zeiss). As a positive control, cell death
was induced by cytokine treatment (0.1 ng/ml IL-1b, 10 ng/ml TNF-a,
and 30 ng/ml IFN-g) for 24 h.
2.14. Luciferase assay
Luciferase activity was measured in MIN6B1 cells with a dual-
luciferase reporter assay (Promega). The RIP-Luciferase reporter
plasmid driven by a 600 bp fragment of the rat insulin 2 promoter has
been previously described [25]. Renilla luciferase activity from the co-
transfected pRL-TK promoter vector (Promega) was used to normalize
the ﬁreﬂy activity for transfection efﬁciency. The renilla luciferase
construct containing the 30UTR of human MTPN [26] was kindly pro-
vided by Dr. Guido Sebastiani, University of Siena. Renilla luciferase
activity was normalized to the ﬁreﬂy activity of the co-transfected
pGL3-promoter vector (Promega).
2.15. Predictions of miRNA target sites
To detect the presence of putative binding sites for the miRNAs
expressed in b-cells (Supplementary Table 3), we scanned the
sequence of circHIPK3 with the Targetscan algorithm [27] using default
parameters.
2.16. Testing circHIPK3 as competing endogenous RNA for miRNA
targets
We ﬁrst retrieved the putative target genes for each miRNA from
several sources (DIANA-microT, ElMMo, miRBase, miRanda, miRDB,
PicTar, PITA and TargetScan) using the MultiMir R package [28]. We
then assessed whether the collected putative targets were included in
the genes differentially expressed upon circHIPK3 silencing and
established if they were up- or downregulated. A signiﬁcant shift in the
distribution of miRNA target expression was assessed using the one-
sided Mann Whitney Utest. Then, we computed the total number of
targets of each miRNA that are differentially expressed (p< 0.05) upon
circHIPK3 silencing, the fraction of them that are up- or downregulated,
and the ratio of downregulated targets over the number of differentially
expressed targets (Supplementary Table 4). We applied the binomialMOLECULAR METABOLISM 9 (2018) 69e83  2018 The Authors. Published by Elsevier GmbH. This is an open a
www.molecularmetabolism.comtest, which allows rejecting the H0 hypothesis that there are as many
miRNA targets up- or downregulated upon circHIPK3 silencing. We
constructed the H1 hypotheses as signiﬁcantly more miRNA targets are
downregulated in the circHIPK3 siRNA sample.
2.17. miRNA target enrichment analysis
For each miRNA of interest, we estimated the average number of
miRNA recognition elements (MREobs) with a perfect seed match (7-
mers) present in the 30 UTR (AGILENT WholeGenome 4X44k v2,
30UTRs downloaded from BioMart [28]) of n downregulated genes
(FDR < 0.05 and fold change > 1.2). To obtain an empirical p value
associated with each MREobs, we independently estimated 100’000
times the average predicted density of miRNA recognition elements
MREbg for N regions of matching length randomly sampled from the 30
UTRs of mouse mRNAs not downregulated in the array (minimum
30UTR length of 10 bp and a GC content above 20%). The same
analysis was also performed using the complete list of miRNAs
expressed in b-cells with 1000 iterations (Supplementary Table 5).
2.18. Data availability
Circular RNA expression proﬁling data of human islet cells and the list
of circRNAs conserved in mouse islets are available under the GEO
accession code GSE105096. Data of whole gene expression proﬁling
of MIN6B1 cells upon circHIPK3 silencing are available under the GEO
accession code GSE105097.
2.19. Statistical analysis
Data are presented as mean  standard deviation. Normality of data
was analyzed using ShapiroeWilk test. Homogeneity of variances was
analyzed using Levene statistics. For statistical comparison to a given
value, one-sample Student’s t test was used. For two groups, statis-
tical differences were assessed by two-tailed unpaired Student’s t test.
In case of multiple comparisons one-way ANOVA was applied followed
by the appropriate parametric or nonparametric post hoc test. Statis-
tical signiﬁcance was considered for p values smaller than 0.05
(GraphPad Prism 7, IBM SPSS Statistics 23).
3. RESULTS
3.1. CircRNAs are abundant in pancreatic islets and insulin-
secreting cell lines
To investigate the potential involvement of circRNAs in the regulation of
b-cell functions, we searched for circular transcripts expressed in
human islet samples using a microarray approach. The array includes
probes spanning over the circularized junction of 5396 previously
annotated circRNAs [6,29]. We detected 3441 of these transcripts in
human islet samples (GSE105096).
The analysis of our previously published RNA sequencing data [23],
revealed that 497 of them possess precise orthologues expressed in
mouse islets (GSE105096). From this list, we picked three circRNAs for
further analysis. We chose the most abundant circRNA, circHIPK3,
which originates from an exonic sequence of Hipk3, and randomly
selected two circRNAs from the top 100 expressed circRNAs, which
derive from sequences of Arhgap12 and Aff1. We also included in our
study ciRS-7/CDR1as, a circRNA which is proposed to act as a sponge
for miR-7 and is involved in the regulation of insulin secretion and b-
cell proliferation [30,31] (Supplementary Table 6).
The expression of each of these circRNAs in b-cell lines and primary
islet cells was conﬁrmed using divergent primers. We indeed detected
ciRS-7 (in agreement with a previous report [32]), along withccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 71
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Figure 1: ciRS-7, circAFF1, circARHGAP12 and circHIPK3 expression across rat tissues and in animal models for diabetes. The expression level of (A) ciRS-7, (B)
circHIPK3, (C) circAFF1, and (D) circARHGAP12 in 16 different rat tissues was assessed by qPCR. The expression was normalized to islet levels (n ¼ 4). (EeH) RNA expression
measured by qPCR in (E) 13e16 weeks old db/db mice (dbþ/þ) versus heterozygous control mice (dbþ/) (n ¼ 5), (F) 13e16 weeks old ob/ob mice (obþ/þ) compared to wildtype
control (ob/) (n ¼ 4), (G) 4 and 8 weeks old NOD mice (n ¼ 4), and (H) 4 and 8 weeks old NOD/SCID mice (n ¼ 3). The expression levels were compared using unpaired
Student’s t-test. Data are represented as mean  s.d. *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 2: circAFF1 controls apoptosis of b-cells. (AeD) Dissociated rat islet cells were transfected with circAFF1 siRNA for 48 h. (A) RNA levels measured by qPCR. Statistical
signiﬁcance was assessed by one-sample Student’s t-test (n ¼ 3). (B) Apoptosis levels with or without cytokine addition for 24 h. Apoptosis was assessed by counting the cells
displaying pycnotic nuclei (n ¼ 5). Statistical signiﬁcance was evaluated by one-way ANOVA followed by GameseHowell post hoc. (CeD) Insulin secretion (C) and insulin content
(D) were assessed upon treatment with either 2 mM or 20 mM glucose (n ¼ 5). Statistical signiﬁcance in insulin secretion was evaluated by one-way ANOVA followed by Gamese
Howell post hoc. Statistical signiﬁcance in insulin content was calculated by one-sample Student’s t-test. Data are represented as mean  s.d. *p < 0.05, **p < 0.01,
***p < 0.001.circARHGAP12, circAFF1, and circHIPK3 in the insulin-secreting cell
lines INS832/13, and MIN6B1, as well as, in mouse, rat, and human
islets. Sequencing of the PCR products conﬁrmed the expected
ampliﬁcation of the circularized junction of the circRNAs (data not
shown). To further verify that these transcripts are truly circular, we
treated MIN6B1 samples with RNase R, an exonuclease that efﬁciently
degrades linear but not circular RNAs [33]. As expected, circHIPK3,
circAFF1, and circARHGAP12 were more resistant to RNase R than
their linear counterparts. Moreover, ciRS-7 was more resistant to the
treatment than Gapdh (there is no corresponding linear transcript of
ciRS-7 expressed in b-cells) (Supplementary Figure 1). Taken
together, these observations conﬁrm the expression of these circular
transcripts in insulin-secreting cells.
3.2. Differential expression of circRNAs in rat tissues
Some circRNAs have been shown to follow a speciﬁc tissue distribution
pattern [8]. For this reason, we measured the level of the selected
circRNAs in different rat tissues (Figure 1AeD). In line with previous
reports [29], ciRS-7 was found to be expressed at the highest level in
brain, at medium level in islets, and at lower levels in the remaining
tissues (Figure 1A). CircHIPK3 was detected in most tissues but was
most abundant in brain and pancreatic islets (Figure 1B). Finally, cir-
cAFF1 and circARHGAP12 were expressed at similar levels across all
the examined tissues (Figure 1C,D).MOLECULAR METABOLISM 9 (2018) 69e83  2018 The Authors. Published by Elsevier GmbH. This is an open a
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Type 2 diabetes
We measured the expression of the selected circRNAs in the islets of
different diabetes animal models. We found that circHIPK3 displays
decreased expression in diabetic db/db mice (Figure 1E), while the
level of ciRS-7 is reduced both in db/db and in ob/ob mice, which are
obese but still normoglycemic (Figure 1E,F). Consistent with data
obtained in the islets of Type 2 diabetic donors [34], the expression of
linear Hipk3 was also diminished in both models. The level of cir-
cARHGAP12 and circAFF1 was not altered in Type 2 Diabetes models,
but a reduction in the expression of circARHGAP12 was observed in the
islets of prediabetic NOD mice, which spontaneously develop Type 1
Diabetes (Figure 1G). The expression of circARHGAP12 was unchanged
in age-matched NOD/SCID mice which do not develop the disease
(Figure 1H), indicating that the observed reduction is not an age-related
effect.
3.4. Role of the selected circRNAs in the control of b-cell activities
We then assessed whether these circRNAs are required to accomplish
specialized b-cells functions. For this purpose, we silenced each of
these transcripts using siRNAs directed against the circularized junc-
tions or against sequences speciﬁc to the circRNAs, and tested the
impact on insulin biosynthesis and secretion, b-cell survival, and
proliferation, which are dysregulated under diabetic conditions.ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 73
Original ArticleWe found that a siRNA speciﬁcally silencing circARHGAP12 and
without any effect on the expression of the corresponding linear
transcript generated from the Arhgap12 locus (Supplementary
Figure 2a) has no effect on proliferation, survival, or insulin secretion
of MIN6B1 cells (Supplementary Figure 2bee). Therefore, the func-
tional role of this transcript was not further investigated.Control si ciRS-7
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Figure 3: Role of ciRS-7 in the control of b-cell functions. Dissociated rat islet cells
Statistical signiﬁcance was assessed by one-sample Student’s t-test (n ¼ 3). (BeC) Insulin
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(Supplementary Figure 3a, Figure 2A) resulted in an increase in
apoptosis comparable to that observed after treatment of the cells with
a combination of proinﬂammatory cytokines (Supplementary Figure 3b,
Figure 2B). In contrast, circAFF1 silencing did not affect the prolifer-
ative capacity of MIN6B1 cells (Supplementary Figure 3c), and did notControl si ciRS-7
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alter insulin content or secretion in response to glucose of MIN6B1
cells or of primary rat b-cells (Supplementary Figure 3dee,
Figure 2CeD).
Xu et al. observed that overexpression of ciRS-7 in MIN6 and mouse
islet cells results in an increase in insulin secretion and content, while
overexpression of miR-7 had the opposite effect [32]. As we found a
reduction in ciRS-7 level in the islets of db/db and ob/ob mice, we
reproduced the decreased expression in wild type b-cells (Figure 3A)
and observed that insulin secretion tends to be reduced (p ¼ 0.058)
while insulin content is unaffected (Figure 3B,C).
Since miR-7 has been shown to control proliferation, we also investi-
gated whether the modulation of ciRS-7 levels affects b-cell replication.%
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Figure 4: Circular HIPK3 regulates apoptosis, proliferation, and insulin secretion of b
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www.molecularmetabolism.comIndeed, silencing of ciRS-7 diminished prolactin-stimulated proliferation
of primary rat b-cells (Figure 3D) without affecting the survival rate
(Figure 3E). We performed the same assays in MIN6B1 cells using a
different siRNA resulting in a similar functional impact (Supplementary
Figure 4aee). These data suggest that alterations of ciRS-7 levels under
diabetic conditions may contribute to b-cell dysfunction.
circHIPK3 is one of the most abundant circRNAs expressed in
pancreatic islets. Using a siRNA directed against the circular junction,
we efﬁciently silenced circHIPK3 in both MIN6B1 cells and rat islets
(Figure 4A, Figure 5B), resulting in an increase in apoptosis
(Supplementary Figure 5a, Figure 4B) and in a negative impact on the
proliferative capacity of the cells. Indeed, prolactin failed to stimulate___________
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Original Articleproliferation of MIN6B1 and primary b-cells containing lower levels of
this circRNA (Supplementary Figure 5b, Figure 4C). Furthermore, upon
silencing of circHIPK3, insulin secretion in response to glucose was
impaired (Figure 4D, Supplementary Figure 5c) and Insulin mRNA
levels were signiﬁcantly lower (Figure 4E, Supplementary Figure 5d).
This resulted in a decrease in insulin content in MIN6B1 cells, but not
in rat islets (Supplementary Figure 5e, Figure 4F). These observations
indicate that appropriate circHIPK3 levels are necessary to maintain
optimal b-cell functions.
3.5. Interconnection of circular and linear Hipk3 isoforms
Since circHIPK3 is involved in the control of important b-cell functions,
the mechanism through which this circular transcript exerts its regu-
latory activity was investigated in more detail.
Surprisingly, we found that, albeit to a lesser extent, linear Hipk3
mRNA levels are signiﬁcantly decreased upon silencing of circHIPK3 in76 MOLECULAR METABOLISM 9 (2018) 69e83  2018 The Authors. Published by Elsevier GmbH.rat islets and MIN6B1 cells (Figure 4A, Figure 5B). In the linear Hipk3
transcript, the sequence targeted by the siRNA against circHIPK3
matches two short separate segments located at the 50 and 30 ends of
exon 2 and should thus not be targeted by the RISC complex
(Figure 5A). Nonetheless, to ensure that these partially matching se-
quences are not sufﬁcient to silence linear Hipk3, we designed a siRNA
targeting the 14 nucleotides at the 5’end of linear Hipk3 with the
remaining nucleotides being scrambled (si circHIPK3-scramble)
(Figure 5A). This siRNA did neither affect the expression of circHIPK3
nor of linear Hipk3 (Figure 5C). These results conﬁrm that circHIPK3
siRNA can directly silence only the circular transcript and indicate that
changes in the expression of linear Hipk3 are indirectly caused by the
drop in circHIPK3 levels. Remarkably, we found that the opposite was
also true. Indeed, a siRNA targeting an exonic sequence of linear Hipk3
(exon 16, si HIPK3.1) (Figure 5A), that is not included in circHIPK3
sequence, not only lowered Hipk3mRNA but also the level of circHIPK3This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Figure 5D). To exclude that this siRNA reduces circHIPK3 by affecting
the pre-spliced RNA, we designed a different Hipk3 siRNA directed
against the splice junction between exons 9 and 10, which cannot bind
to the un-spliced RNA (si HIPK3.2) (Figure 5A). Likewise, this siRNA
decreased the levels of both linear Hipk3 and circHIPK3 (Figure 5E)
conﬁrming that the expression of the two transcripts is tightly linked.
Due to the interconnection of circHIPK3 and Hipk3 expression we
wondered whether the functional effect observed upon silencing of
circHIPK3 is indirectly mediated by the decrease in Hipk3 levels.
Interestingly, linear Hipk3 displays an expression pattern similar toControl si HIPK3
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(Supplementary Figure 6a). Shojima et al. investigated the role of
HIPK3 in the control of insulin secretion in Hipk3/ mice [35]. They
observed that both insulin content and glucose-stimulated insulin
secretion are decreased in Hipk3 knockout mice and in wild-type
mouse islets treated with a siRNA against Hipk3. In our hands,
silencing of Hipk3 in MIN6B1 cells did not alter insulin secretion, yet
insulin content was signiﬁcantly decreased (Figure 6A,B). Similar to
circHIPK3, silencing of linear Hipk3 reduced Insulin mRNA levels
(Figure 6C), as well as, insulin promoter activity in MIN6B1 cellsControl si HIPK3
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Original Article(Figure 6D) without affecting the expression of several transcription
factors known to control insulin biosynthesis (Supplementary
Figure 6b). Furthermore, silencing of linear Hipk3 in MIN6B1 cells
induced apoptosis similar to circHIPK3 (Figure 6E). However, the
proliferative capacity was not reduced in MIN6B1 cells after silencing
of Hipk3 and stimulation with prolactin (Figure 6F). These data indicate
that circHIPK3 and Hipk3 have similar impacts on b-cell activities.
3.6. CircHIPK3 regulates the expression of key b-cell genes
We then carried out a series of experiments to determine the mode of
action of circHIPK3. We ﬁrst assessed whether this circular transcript
controls Insulin mRNA levels by affecting the activity of the insulin
promoter. Indeed, we found that the activity of the insulin promoter is
altered by modulating the level of circHIPK3 in MIN6B1 cells
(Figure 7A). Nevertheless, the expression of several transcription
factors controlling Insulin mRNA was not modiﬁed by circHIPK3
knockdown, indicating that circHIPK3 is likely to act at the translational
or post-translational level (Figure 7B).
To obtain a broader picture of the mechanisms underlying the multiple
effects of circHIPK3, we analyzed by microarray the global mRNA
expression changes caused by the silencing of this circular transcript
(GSE105097). Consistent with the observed functional effects,
pathway analysis of the differentially expressed transcripts revealed a
downregulation of genes involved in insulin secretion (Supplementary
Figure 6c). Surprisingly, the main upregulated pathway was olfactory
signaling, which was previously shown to be associated to Type 2
Diabetes and paternal high fat diet [36,37]. The changes in the
expression of several key genes, including Akt1, Slc2a2, and Mtpn,
which are downregulated upon circHIPK3 silencing, were conﬁrmed by
qPCR (Supplementary Figure 6d). Similar changes in gene expression
upon circHIPK3 knockdown were also detected in rat (Figure 7C) and in
human islets (Figure 7D). Taken together, these data show that
circHIPK3 regulates glucose-stimulated insulin secretion, insulin
biosynthesis, proliferation, and apoptosis by affecting the expression of
key genes associated with these functions. Interestingly, except for
Cckar, silencing of the linear Hipk3 transcript did not affect the
expression of these genes (Figure 7E), indicating that linear HIPK3 and
circHIPK3 might act via different pathways.
3.7. Part of the effects of circHIPK3 may be mediated via miRNA
sponging
CircHIPK3 has been proposed to act as a sponge for several miRNAs
[15,38], many of which control the activities of b-cells. To assess to
what extent the changes in mRNA expression observed upon circHIPK3
silencing may be driven by miRNA sponging, we used a computational
approach to identify miRNA seed sites present within the sequence of
this circRNA. We found that circHIPK3 contains potential binding sites
for several miRNAs expressed in b-cells (Supplementary Figure 7a,
Supplementary Table 3). We then exploited our microarray data by
analyzing the level of all the genes targeted by these miRNAs dis-
playing changes >1.2 fold and a p-value < 0.05 after circHIPK3
silencing. In line with the sponge hypothesis, the putative targets of
several miRNAs expressed in b-cells were preferentially down-
regulated upon silencing of circHIPK3 using a binomial test
(Supplementary Figure. 7b and c, Supplementary Table 4). The dis-
tribution of the targets of 59 of these miRNAs was also signiﬁcantly
reduced using a one sided ManneWhitney U-test (Figure 8A,B,
Supplementary Table 4). At the top of this list we found miRNAs with
known functions in b-cells, which have been previously shown to bind
to circHIPK3, namely miR-124-3p, miR-338-3p, miR-29b-3p, and
miR-30 [15,39e44].78 MOLECULAR METABOLISM 9 (2018) 69e83  2018 The Authors. Published by Elsevier GmbH.For these miRNAs, the number of targets within the differentially
expressed genes ranges from 28 for miR-338-3p to 242 for miR-124-
3p, out of which most are downregulated (Figure 8AeC). To verify the
relevance of this effect, we ran the same analysis for two other abundant
miRNAs, miR-7-5p and miR-375-3p, which possess several putative
targets within the differentially expressed genes. In this case, we did not
ﬁnd any signiﬁcant enrichment toward downregulation (Figure 8AeC).
To further conﬁrm these observations, we performed a miRNA-target
enrichment analysis using a random sampling procedure. For this
purpose, we compared the number of miRNA response elements (MRE)
in the 30UTRs of the signiﬁcantly downregulated genes (FDR < 0.05)
(MREobs) with the number of miRNA response elements in 30UTRs of
genes unaffected upon circHIPK3 silencing (MREbg) (Supplementary
Table 5). Using this computational approach, that takes into account
potential bias due to differences in the 30UTR length and GC content, we
conﬁrmed an enrichment of miR-338-3p and miR-124-3p binding sites
in the 30UTRs of the downregulated genes (Figure 8D).
To elucidate whether circHIPK3 can indeed sponge these miRNAs, we
ﬁrst measured the expression of these miRNAs upon silencing of
circHIPK3. We found that a decrease in circHIPK3 level does not affect
the levels of miR-124-3p, miR-338-3p or miR-29b (Figure 7F). Since
miRNA sponging does not imply changes in the expression of the
respective miRNA [45], we analyzed the activity of a luciferase
construct containing the 30UTR of human MTPN, which has been
shown to be controlled by miR-124-3p [39]. Indeed, silencing of
circHIPK3 resulted in a drop in luciferase activity consistent with a rise
in the repressive activity of miR-124-3p (Figure 7G).
Taken together, these data indicate that the gene expression changes
observed upon circHIPK3 silencing could at least partly be mediated by
increasing the repressive activity of a group of miRNAs that control the
functions of b-cells, including miR-124-3p and miR-338-3p.
4. DISCUSSION
In this study, we detected more than 3000 previously annotated
circRNAs, showing that these transcripts are abundant in islets. Recent
estimates indicate that human cells may express up to 160,000
circRNAs [15,46]. Therefore, the array is likely to cover only a small
fraction of the circRNAs expressed in human islet cells. We were able
to detect about 500 (14.4%) of these circRNAs in RNA sequencing data
from mouse islets, indicating that at least a fraction of them is
evolutionary conserved. A similar degree of conservation has been
observed by Memczak et al. comparing circRNAs expressed in human
and mouse cells [29].
We selected four exonic circRNAs for further investigations and, in line
with previous reports [47], we found that their sequences were well
conserved between rat, mouse, and human cells. The analysis of the
level of these circRNAs in different Type 1 and Type 2 Diabetes models
revealed that circARHGAP12 expression is reduced in the islets of
prediabetic NOD mice. The functional role of this circRNA in b-cells
remains to be deﬁned since silencing of this transcript does not affect
proliferation, apoptosis, or insulin secretion. The level of circAFF1 is
unaffected in the investigated diabetes models but silencing of
circAFF1 led to apoptosis. Future experiments will need to determine
whether the expression of this transcript is modulated in pathological
conditions associated with alterations in b-cell survival.
ciRS-7 and circHIPK3, two of the studied circRNAs that are highly
abundant in pancreatic islets, were found to be differentially expressed
under diabetic conditions and to play important roles in the control of
b-cell functions. The level of ciRS-7 is decreased both in ob/ob and db/
db mice, which are severely obese due to the lack of leptin or of theThis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 7: CircHIPK3 regulates the expression of important genes controlling b-cell functions. (A) Rat insulin promoter activity was measured 48 h after transfection with a
ﬁreﬂy luciferase construct driven under the control of the rat insulin promoter and circHIPK3 siRNA (n ¼ 3). Statistical signiﬁcance was assessed using one-sample Student’s t-test.
MIN6B1 cells (B,EeG), dispersed rat islet cells (C), or dispersed human islet cells (D) were transfected for 48 h with circHIPK3 siRNA (BeD, FeG) or Hipk3 siRNA (E). (BeF) RNA
level measured by qPCR (n ¼ 3e7). Statistical signiﬁcance was assessed using one-sample Student’s t-test. (G) Activity of a luciferase construct containing the 30 UTR of human
MTPN (n ¼ 3). Statistical signiﬁcance was assessed using one-sample Student’s t-test. Data are represented as mean  s.d. *p < 0.05, **p < 0.01, ***p < 0.001.
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79
Figure 8: circHIPK3 might sponge miRNAs in MIN6B1 cells. (A) Expression of predicted miRNA targets signiﬁcantly changing in circHIPK3 siRNA samples versus control
samples measured by microarray. (B) Statistical analysis of the distribution of predicted miRNA targets signiﬁcantly changing in circHIPK3 siRNA versus control samples. Bars
represent elog10 p-value of the one-sided Mann Whitney Utest for several miRNAs. Number of predicted miRNA targets are indicated within each bar. (C) Differential expression
analysis of control versus circHIPK3 siRNA samples of predicted miRNA targets represented with the log2 fold-change and e log10 p-value. Signiﬁcantly changing miRNA targets
are displayed with black dots, not signiﬁcantly changing targets with grey dots. The dotted lines represent the thresholds used for the analysis (p-value < 0.05 and absolute fold
change > 1.2). (D) MiRNA target enrichment analysis for miR-338-3p and miR-124-3p, as well as, miR-7a-5p as a control. Number of miRNA response elements in the 30UTRs of
signiﬁcantly downregulated genes (MREobs) was compared to 30UTRs of not signiﬁcantly changing genes (MREbg). Signiﬁcance was computed by comparing MREobs versus MREbg
using random sampling analysis.
Original Article
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leptin receptor, respectively. In contrast to db/db mice, which are
diabetic, ob/ob mice are able to compensate for the increased insulin
demand linked to obesity but are nonetheless prone to diabetes
development. Therefore, the decrease in ciRS-7 levels observed in ob/
ob and db/db mice is consistent with an involvement in diabetes
development. CiRS-7 has been proposed to act as a sponge for miR-7
[48]. In agreement with this hypothesis, Piwecka et al. observed a
deregulation of miR-7 in ciRS-7 knock-out mice probably due to the
lack of stabilisation of this miRNA by the circular transcript [49]. CiRS-7
also possesses 22 seed sites for the miR-876-5p/3167 family [14], but
these miRNAs are not expressed in b-cells and are unlikely to
contribute to the functional effects of ciRS-7. Overexpression of ciRS-7
has been reported to increase glucose-stimulated insulin secretion and
content [19]. In our hands insulin release tended to be decreased upon
ciRS-7 silencing, but not insulin content, partially conﬁrming the ob-
servations of Xu et al. [19]. We observed a similar phenotype in
MIN6B1 cells upon silencing ciRS-7 using a different siRNA ruling out
the possibility of off-target effects mediated by the siRNA. Altogether,
the functional impact we observed upon modulating ciRS-7 level is in
line with a diabetes phenotype.
CircHIPK3 is one of the most abundant circRNAs present in pancreatic
islets. This circRNA originates from exon 2 of Hipk3, a gene displaying
diminished expression in the islets of Type 2 diabetic patients [34]. We
found that linear Hipk3 is decreased in both ob/ob and db/db mice,
conﬁrming a potential involvement in diabetes development. Shojima
et al. observed that glucose-stimulated insulin secretion and content are
reduced in Hipk3/ mice and in isolated islets in which linear Hipk3 is
silenced [35]. Using our siRNA against linear Hipk3, we did not ﬁnd a
signiﬁcant decrease in insulin secretion, but we conﬁrmed a reduction in
insulin content accompanied by a decrease in the insulin promoter
activity. The phenotype of Hipk3/ mice may at least in part be linked
to the absence of circHIPK3. Indeed, the before mentioned publication
does not provide any information about the region that has been deleted
in Hipk3/ mice. Therefore, these animals may lack exon 2 and hence
circHIPK3. Moreover, as discussed below, even if this is not the case, the
absence of linear Hipk3 may indirectly result in a decrease in circHIPK3
levels. Besides its effect on insulin secretion, we found that silencing of
linear Hipk3 in MIN6B1 cells causes a rise in the apoptotic rate. These
ﬁndings are consistent with the protective effect of HIPK3 against
apoptosis observed in prostate cancer cells [50].
The expression of circHIPK3 is decreased in the islets of diabetic db/db
mice, which display reduced insulin content, a diminished capacity to
secrete insulin in response to glucose, and b-cell atrophy [20,51].
Silencing of circHIPK3 in b-cells resulted in a similar phenotype, sug-
gesting that the drop in the level of this circular transcript may contribute
to the events occurring during Type 2 Diabetes development.
Reduction of circHIPK3 levels using a siRNA induces apoptosis and
decreases prolactin-stimulated b-cell proliferation. An analogous ef-
fect on proliferation was reported in several other human cell lines
[15,43]. In contrast, silencing of circHIPK3 in bladder cancer cells
increases migration and tumor invasion [38]. This effect was proposed
to be exerted by sequestering miR-558, which is not expressed in b-
cells. Thus, circHIPK3 may accomplish cell-speciﬁc tasks according to
the presence or absence of particular interaction partners. In addition
to the effects on b-cell survival, silencing of circHIPK3 led to defective
glucose-induced insulin secretion. Moreover, modulation of circHIPK3
levels modiﬁed the insulin content by regulating the activity of the
insulin promoter of MIN6B1 cells but not of rat islets. This may be
explained by the fact that primary b-cells contain much higher insulin
levels compared to cell lines and may be less affected by relatively
small and acute decreases in insulin biosynthesis.MOLECULAR METABOLISM 9 (2018) 69e83  2018 The Authors. Published by Elsevier GmbH. This is an open a
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transcriptional changes occurring upon silencing of this circular tran-
script. This resulted in the down-regulation of numerous genes
involved in insulin secretion and PI3K-Akt signalling. AKT plays major
roles in glucose-stimulated insulin secretion, apoptosis, and is a key
player in the PI3K-pathway regulating b-cell proliferation [52].
Silencing of circHIPK3 also resulted in a decrease in Mtpn expression,
an important component of the machinery controlling insulin secretion
[26], and of Slc2a2 encoding Glut2, an essential transporter for
glucose uptake in b-cells [53]. Thus, the microarray data are in line
with the observed phenotype and give some insight into the mode of
action of circHIPK3.
The observed changes in gene expression can potentially be caused in
cis or in trans. A computational analysis revealed that the genes
downregulated upon circHIPK3 silencing are enriched for the targets of
several miRNAs, including miR-124-3p, miR-29-3p, miR-338-3p, and
miR-30, which have known functions in b-cells. In fact, miR-29 family
members, as well as, miR-124-3p regulate insulin secretion [26,42]. In
contrast, blockade of miR-338-3p promotes b-cell proliferation and
survival under pro-apoptotic conditions [40,54], and miR-30 family
members are involved in islet differentiation [44]. Interestingly,
circHIPK3 was previously shown to directly bind to miR-124-3p, miR-
29b-3p, and miR-338-3p [15], and other studies reported interactions
of this circular transcript with miR-30 and miR-558 [38,43]. Hence, the
functional effects of circHIPK3 silencing might at least in part be
mediated by a consequent increase in the repressive activity of these
miRNAs. In agreement with this hypothesis, we found that circHIPK3
modulates the expression of a luciferase reporter containing the 30UTR
of MTPN, which is controlled by miR-124-3p [26].
Silencing of linear and circular Hipk3 transcripts have different impacts
on gene expression pointing to a different mode of action despite
sharing similar functional effects. However, in b-cells the expression of
circular and linear Hipk3 appears to be tightly interconnected. Using
the same siRNA sequence used in this study, several groups working
in different other cell types [15,43] did not report changes in linear
Hipk3 upon silencing of circHIPK3. Thus, the tight interconnection
between circular and linear Hipk3 expression may be a cell-type
speciﬁc feature. Certain circRNAs share miRNA seed sites with the
30UTR of their parent gene [16,55]. This enables them to control the
level of their corresponding linear isoforms by sequestering the
miRNAs and preventing their repressive activity. The sequence of
circHIPK3 contains seed sites for numerous miRNAs present in the
30UTR of Hipk3 mRNA that may contribute to the coordination of the
expression of the circular and linear transcripts. Another possible
mechanism linking linear and circular Hipk3 expression involves the
regulation of the Hipk3 promoter. Indeed, the product of the Hipk3
gene is a kinase that phosphorylates different transcription factors
including c-Jun. Since phosphorylated c-Jun activates the Hipk3
promoter [50], this might elicit a feedforward cycle that sustains the
expression of the gene. Thus, silencing of Hipk3 may potentially lead to
a reduction in the Hipk3 promoter activity, and consequently, to a
concurrent knockdown of circHIPK3.
5. CONCLUSION
We found that circRNAs are abundant in human islets and are
conserved between species. CiRS-7 and circHIPK3 contribute to the
regulation of essential b-cell activities and display altered expression
in diabetes models, suggesting that they may be implicated in the
development of this disease. A better understanding of the role of these
newly discovered forms of RNA promises to shed new light on theccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 81
Original Articlemechanisms causing b-cell failure under diabetic conditions and may
lead to the discovery of new strategies to prevent or treat this very
common metabolic disorder.
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